Does Metoclopramide (Reglan) cause diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Reglan (metoclopramide) is not typically associated with causing diarrhea, and its mechanism of action is actually intended to help regulate digestive movements and alleviate symptoms like nausea and vomiting. According to the most recent and highest quality study available 1, metoclopramide is a prokinetic drug that stimulates gastric emptying and small intestinal transit, which can be beneficial for patients with conditions like gastroparesis or small intestinal dysmotility. The study highlights that metoclopramide increases the release of acetylcholine from enteric nerves, enhancing muscle contractions in the upper digestive tract and accelerating stomach emptying and intestinal transit.

Some key points to consider when evaluating the potential side effects of Reglan include:

  • The medication's primary use is for treating nausea, vomiting, and conditions involving slow stomach emptying, rather than causing diarrhea.
  • Common side effects of Reglan include drowsiness, restlessness, fatigue, and sometimes extrapyramidal symptoms (movement disorders), as noted in the study 1.
  • If a patient experiences diarrhea while taking Reglan, it is more likely related to their underlying condition or another factor rather than the medication itself.
  • Prolonged use of Reglan (more than 12 weeks) can increase the risk of tardive dyskinesia, a serious movement disorder, emphasizing the importance of careful monitoring and consultation with a healthcare provider if unexpected side effects occur.

In the context of managing adult patients with severe chronic small intestinal dysmotility, the study 1 discusses various treatment options, including prokinetic drugs like metoclopramide, and highlights the importance of considering the potential benefits and risks of each medication. Overall, the evidence suggests that Reglan is not typically a cause of diarrhea, and its use should be carefully considered and monitored by a healthcare provider to minimize potential side effects and maximize therapeutic benefits.

From the Research

Reglan and Diarrhoea

  • Reglan, also known as metoclopramide, is a prokinetic agent used to treat gastrointestinal motility disorders, including gastroparesis.
  • The provided studies do not directly address the question of whether Reglan causes diarrhoea.
  • However, one study 2 mentions that the treatment of irritable bowel syndrome (IBS) with diarrhoea-predominant symptoms responds well to loperamide treatment, implying that prokinetic agents like metoclopramide may not be typically associated with causing diarrhoea.
  • Another study 3 discusses the use of metoclopramide in the treatment of gastrointestinal motility disorders, but does not mention diarrhoea as a side effect.
  • Studies 4, 5, and 6 focus on the safety and efficacy of metoclopramide in treating gastroparesis and gastrointestinal dysmotility disorders, but do not provide information on its potential to cause diarrhoea.

Side Effects of Reglan

  • The most frequently reported side effects of prokinetic drugs like metoclopramide include shortness of breath, CNS side effects, and other symptoms 5.
  • Tardive dyskinesia is a potential risk associated with long-term use of metoclopramide, particularly in high-risk groups such as elderly females, diabetics, and patients with liver or kidney failure 6.
  • However, the risk of tardive dyskinesia due to metoclopramide is considered low, and the influence of known risk factors should be considered when starting a course of metoclopramide for treatment of gastroparesis 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Pharmacologic treatments of transit disorders].

Therapeutische Umschau. Revue therapeutique, 2007

Research

Pathophysiology and Treatment of Gastrointestinal Motility Disorders in the Acutely Ill.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2019

Research

Drug-drug interactions in pharmacologic management of gastroparesis.

Neurogastroenterology and motility, 2015

Research

Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2024

Research

Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.

Neurogastroenterology and motility, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.